We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.89%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$74.4B
AUM Growth
+$7.26B
(+11%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
19.47%
Holding
3,107
New
25
Increased
2,535
Reduced
421
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$141M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$96.6M |
| 4 |
Amazon
AMZN
|
+$63.7M |
| 5 |
Prologis
PLD
|
+$47.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$56.3M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$36M |
| 3 |
Y
Alleghany Corp
Y
|
+$33M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$26.6M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$20.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.05% |
| 2 | Healthcare | 14.94% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 10% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Bionano Genomics
BNGO
$13.3M
| $675K | ﹤0.01% |
771
+11
| +1% | +$13.8K |
|
2327
i3 Verticals
IIIV
$342M
| $675K | ﹤0.01% |
27,713
+721
| +3% | +$16.3K |
|
|
BHR
2328
Braemar Hotels & Resorts
BHR
$142M
| $671K | ﹤0.01% |
163,224
+41,247
| +34% | +$169K |
|
|
OLPX
2329
DELISTED
Olaplex Holdings
OLPX
| $671K | ﹤0.01% |
128,782
-107
| -0.1% | -$635 |
|
2330
Bladex Inc
BLX
$2.14B
| $668K | ﹤0.01% |
41,252
+612
| +2% | +$9.49K |
|
2331
LendingTree
TREE
$451M
| $667K | ﹤0.01% |
31,277
+703
| +2% | +$16K |
|
|
VMEO
2332
DELISTED
Vimeo
VMEO
| $667K | ﹤0.01% |
194,388
+3,253
| +2% | +$12.6K |
|
|
CTEV
2333
Claritev Corp
CTEV
$556M
| $667K | ﹤0.01% |
14,511
-29
| -0.2% | -$2.32K |
|
2334
SI-BONE Inc
SIBN
$834M
| $666K | ﹤0.01% |
48,990
+7,478
| +18% | +$109K |
|
2335
Kiniksa Pharmaceuticals
KNSA
$5.93B
| $665K | ﹤0.01% |
44,410
+1,427
| +3% | +$20.8K |
|
2336
Farmers National Banc Corp
FMNB
$930M
| $664K | ﹤0.01% |
47,040
+253
| +0.5% | +$3.57K |
|
2337
NRC Health Common Stock
NRC
$450M
| $664K | ﹤0.01% |
17,803
+155
| +0.9% | +$6K |
|
2338
BioXcel Therapeutics
BTAI
$27.8M
| $663K | ﹤0.01% |
1,928
+31
| +2% | +$7.5K |
|
2339
ProFrac Holding
ACDC
$787M
| $661K | ﹤0.01% |
26,240
+14,815
| +130% | +$327K |
|
2340
Alkami Technology
ALKT
$2.11B
| $658K | ﹤0.01% |
45,094
+1,751
| +4% | +$24.4K |
|
2341
AvePoint
AVPT
$2.71B
| $657K | ﹤0.01% |
159,920
+5,344
| +3% | +$22.9K |
|
2342
Victory Capital Holdings
VCTR
$6.65B
| $657K | ﹤0.01% |
24,506
+1,335
| +6% | +$37.5K |
|
|
REVG
2343
DELISTED
REV Group
REVG
| $656K | ﹤0.01% |
52,007
-676
| -1% | -$8.9K |
|
|
ZIMV
2344
DELISTED
ZimVie
ZIMV
| $656K | ﹤0.01% |
70,269
+1,474
| +2% | +$12.9K |
|
2345
Hayward Holdings
HAYW
$3.36B
| $654K | ﹤0.01% |
69,624
-355
| -0.5% | -$3.3K |
|
2346
Smith & Wesson
SWBI
$637M
| $654K | ﹤0.01% |
75,371
+990
| +1% | +$10.4K |
|
|
ORGN
2347
DELISTED
Origin Materials
ORGN
| $652K | ﹤0.01% |
4,716
+42
| +0.9% | +$6.69K |
|
2348
Beazer Homes USA
BZH
$907M
| $649K | ﹤0.01% |
50,851
+269
| +0.5% | +$3.27K |
|
|
SHCR
2349
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $649K | ﹤0.01% |
405,756
+43,491
| +12% | +$80.5K |
|
2350
Mid Penn Bancorp
MPB
$952M
| $641K | ﹤0.01% |
21,374
+285
| +1% | +$9.16K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2022 Portfolio in Review
As of Q4 2022, RhumbLine Advisers held 3,107 positions worth $74.4B, up 11% from $67.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
RhumbLine Advisers deployed $2.46B of net new capital in Q4 2022, opening 25 new positions and adding to 2,535 existing holdings. Its largest new stake was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Steel Dynamics, an estimated $18.8M trimmed.
- RhumbLine Advisers's largest Q4 2022 buy was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
- RhumbLine Advisers added most to Microsoft in Q4 2022, an estimated $141M increase.
- RhumbLine Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $18.8M.
- RhumbLine Advisers fully exited Twitter, Inc. in Q4 2022, selling an estimated $56.3M.
- RhumbLine Advisers's ten largest holdings make up 19% of its $74.4B portfolio in Q4 2022.
- RhumbLine Advisers opened 25 new positions and closed 97 in Q4 2022.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $74.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.